<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE169152" accession="SRP311209">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP311209</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA715442</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE169152</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>RNAseq_nalm6 and Sem_Asparaginase_Ibrutinib</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Transcriptome Analysis"/>
      <STUDY_ABSTRACT>To determine how inhibition of BTK synergizes with ASNase, we performed RNA sequencing investigating which genes are affected in response to ASNase, ibrutinib or the combination Overall design: Nalm6 and Sem cells were either left untreated or treated for 24h 10um Ibrutinib, 1 IU/ml Asparaginase or a combination of both drugs.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE169152</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
